Tirzepatide (Mounjaro, Zepbound) is an FDA-approved medication for type 2 diabetes and chronic weight management that works by activating both GIP and GLP-1 receptors
but also, it's something that people understand," Henry said
If your insurer covers Wegovy for obesity, and you meet the BMI criteria (30+ or 27+ with a comorbidity like prediabetes), you may have an easier path to coverage
However, it's essential to use it under a doctor's guidance and not solely for weight loss purposes
Much data on the long-term effects of Cymbalta and other antidepressants is derived from studies on rats, guinea pigs, and other animals, where 21 days is considered long-term
More serious potential risks include pancreatitis, gallbladder disease, and hypoglycemia when used with other glucose-lowering medications